The latest research supports immune checkpoint inhibitor therapy for clear cell and non–clear cell renal cell carcinoma, but patient selection is key to optimize outcomes, according […]

Despite an expanding arsenal of disease-modifying antirheumatic drugs (DMARDs), many patients with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA) still struggle to reach remission even after […]

Advances in breast cancer detection and treatment over the past decades have led to an increase in the number of women diagnosed at earlier stages and […]

NASHVILLE, Tennessee — For the first time, the majority of patients with multiple sclerosis (MS) in the United States are, or soon will be, over age […]

VIENNA — Results from the phase 3 SELECT-GCA study showed that the Janus kinase (JAK) inhibitor upadacitinib (Rinvoq) induces significant and sustained remission in people with […]

VIENNA — Anti-Ro/SSA antibodies may help predict which patients with systemic sclerosis (SSc) are at a greater risk for interstitial lung disease (ILD) and may serve […]

Malaria is the world’s leading parasite-related endemic disease. The African region alone accounts for 94% of cases. Infections caused by Plasmodium falciparum, the deadly species, are […]

VIENNA — In patients with rheumatoid arthritis (RA), Janus kinase inhibitors (JAKi) are associated with a substantially greater risk for herpes zoster, but the risk for […]

A new federal effort aims to crack down on illegal e-cigarettes, such as Elf Bar, with the goal of reducing young people’s access to the addictive […]